CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 371

Industry reads hand-picked by our editors

Jun 29, 2015

Reuters
Egalet says its painkiller less likely to be abused
WSJ
Why gene-editing tech has scientists excited
Reuters
Vitae-Boehringer diabetes drug flops as add-on therapy

Jun 26, 2015

Reuters
Celladon may liquidate as it suspends gene therapy development
FierceBiotech
Alexion gets EU green light for pair of rare disease drugs
RAPS
Roche still resisting Avastin use for wet AMD

Jun 25, 2015

Healthcare Dive
Supreme Court rules 6-3 to preserve Obamacare subsidies
Reuters
Polish parliament passes bill on right to IVF treatment
Reuters
Lilly wins Alimta drug patent case

Jun 24, 2015

Reuters
Google Genomics adds Broad Institute's DNA analysis toolkit
FierceBiotech
Sanofi's ousted CEO moves to make a biotech comeback
Los Angeles Times
Buzz kill: Review of marijuana literature finds little reliable efficacy evidence

Jun 23, 2015

FierceBiotech
Aimmune nabs a 'breakthrough' for peanut allergy drug
Kaiser Family Foundation
Poll: Nearly 75% of Americans blame drug makers for 'unreasonable' prescription costs
Reuters
In twist, scientists join tobacco companies to fight cancer

Jun 22, 2015

Reuters
MERS outbreak now No. 1 aviation sector risk
Reuters
Glaxo sells two vaccines to Pfizer
FiercePharma
Could Glaxo be a match for J&J, Roche?

Jun 19, 2015

FierceBiotech
Aimmune nabs a 'breakthrough' for peanut allergy drug
Reuters
Bayer to invest $4.5B in R&D this year
Reuters
China rejects patent linked to Sovaldi

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by ProBio CDMO
Trendline
Inside the market strategies of today’s drugmakers Supported by Evaluate
Trendline
The latest developments on the gene therapy frontier Supported by Mirus Bio LLC

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
2026 Life Sciences AI & Data Predictions Webinar - on demand • Provided by Snowflake
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.